Gilead Sciences (NASDAQ:GILD)

automatic inspection machine

How Analysts Value Gilead Now After Earnings

Gilead Sciences Inc. (NASDAQ: GILD) reported fourth-quarter financial results on Tuesday. As a result, analysts weighed in on this biotech giant and in what direction it might go next. The ...
Read Full Story »
Test tubes

Gilead Rises on Solid HCV Sales and Earnings Beat

Gilead Sciences Inc. (NASDAQ: GILD) reported fourth-quarter financial results after the markets closed on Tuesday. The company had $3.32 in earnings per share (EPS) on $8.51 billion in revenue, versus ...
Read Full Story »
Stock Price

Tesla Hits 52-Week Low

February 2, 2016: Here are five stocks trading with heavy volume among 209 equities making new 52-week lows today. Tesla Motors Inc. (NASDAQ: TSLA) dropped about 8.5% on Tuesday, posting a ...
Read Full Story »
automatic inspection machine

What Expect From Gilead Earnings

Gilead Sciences Inc. (NASDAQ: GILD) is set to release its fourth-quarter earnings report after the markets close on Tuesday. Thomson Reuters consensus estimates call for $3.00 in EPS on $8.13 ...
Read Full Story »
Stock Price

The 52-Week Low Club for Monday

February 1, 2016: Here are four stocks trading with heavy volume among 96 equities making new 52-week lows today. Gilead Sciences Inc. (NASDAQ: GILD) dropped about 0.9% on Monday to ...
Read Full Story »
ThinkstockPhotos-481735362

The 4 Largest Biotech Stocks Are Cheaper Than S&P 500

When some investors think about biotech, the first thoughts are of incredibly volatile companies, with clinical data and binary outcomes that can make the stocks swing up and down wildly. ...
Read Full Story »
Stock Price

The 52-Week Low Club for Friday

January 29, 2016: Here are four stocks trading with heavy volume among 119 equities making new 52-week lows today. Gilead Sciences Inc. (NASDAQ: GILD) dropped about 5.8% on Friday to ...
Read Full Story »
biotech word cloud

Short Sellers Increase Bets in Major Biotechs

The short interest data are out for the January 15 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can ...
Read Full Story »
biotech word cloud

Despite Market and Sector Risks, Why Credit Suisse Now Loves Top Biotechs

Credit Suisse sees solid fundamentals, despite a harsh market landscape, for large-cap biotech firms. There is a challenging macro setup, but headwinds combined with a relatively attractive valuation could carry ...
Read Full Story »
bull and bear

Top Analyst Upgrades and Downgrades: AMD, Amazon, Celgene, Comerica, Fortinet, Gilead, Lennar, Netflix, Voya, Wayfair and Many More

Stocks were getting bruised on Wednesday with overseas pressure and oil sending Dow (-250) and S&P (-29) futures down yet again. Investors have to be thinking that 2016 is becoming ...
Read Full Story »
choose happiness

The Unusual Merrill Lynch Upgrade of Gilead Sciences

Gilead Sciences Inc. (NASDAQ: GILD) is the recent recipient of a curious analyst upgrade. The broad markets are sliding even lower and dragging most companies down with them, especially the ...
Read Full Story »
analysis

Top Analyst Upgrades and Downgrades: Best Buy, 3D Systems, EA, Gilead, Nokia, Shire, United Rentals and Many More

Stocks bounced on Thursday, but Friday's early trading indications were looking for a sharp sell-off of almost 2%, based on more oil and China weakness. This is also ahead of ...
Read Full Story »
Test tubes

Short Interest Remains Mixed for Major Biotechs

The short interest data are out for the December 31 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can ...
Read Full Story »
Medicine pills

4 Pharmaceutical Stocks With Big Catalysts Pending in 2016

This is going to be a big year in biotech, with a host of drugs set to undergo U.S. Food and Drug Administration (FDA) scrutiny. While picking up an exposure ...
Read Full Story »
bull and bear

Top Analyst Upgrades and Downgrades: Bluebird Bio, Check Point, Comcast, Eli Lilly, Hyatt, Lockheed Martin, Rite Aid and Many More

Stocks were pounded lower yet again on Wednesday, but this time on fears of a North Korean hydrogen bomb test. The stock market is off to a rocky start in ...
Read Full Story »